Sign inJoin waitlistJoin the waitlist

Christine Auberle

Curriculum Leader · Washington University/B-JH/SLCH Consortium

Credentials: · · · ·

History

Washington University/B-JH/SLCH Consortium
Present
Washington University in St. Louis
Present
Washington University in St. Louis
Present

Internal Medicine
Washington University/B-JH/SLCH Consortium
Chief Resident2021–2022
2026–Present
Medical Oncology
2024–2026
Washington University School of Medicine
2025–2026
University of Kentucky College of Medicine
2014–2018

Research

Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival
Cardio-Oncology · 2023 · First of 4 authors · Corresponding · 16 citations
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer
Journal of Thoracic Disease · 2024 · First of 10 authors · 6 citations
Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Cancer Medicine · 2026 · 1 citations

BK
Brendan Knapp
3 papers · 3 as a fellow
Douglas Adkins
3 papers
JZ
Jesse Zaretsky
3 papers · 1 as a fellow
Peter Oppelt
3 papers
Saima Waqar
2 papers
Alex Harbison
1 paper
Amanda Cashen
1 paper
AR
Amna Ramadan
1 paper · 1 as a resident
Anthony Apicelli
1 paper
Benjamin Wahle
1 paper · 1 as a fellow
DL
Daniel Lenihan
1 paper
DM
Daniel Morgensztern
1 paper

Clinical trials

5-Fluorouracil Response and Optimization STudy (The FROST Trial)
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2026–2031
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Principal investigator · Terminated · Phase 1, Phase 2
Washington University School of Medicine
2023–2026
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Site PI · Not yet recruiting · Phase 3
Corbus Pharmaceuticals Inc.
2026–2029
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Takeda
2025–2029